Real world study assessment of healthcare resource utilisation and direct medical costs in patients with COPD receiving LAMA/LABA therapy in England
Latest Information Update: 04 Sep 2023
At a glance
- Drugs Aclidinium bromide/formoterol (Primary) ; Glycopyrrolate/indacaterol (Primary) ; Olodaterol/tiotropium bromide (Primary) ; Umeclidinium/vilanterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
Most Recent Events
- 14 Jan 2022 New trial record
- 01 Jan 2022 Results published in the 24th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research